Upcoming Webinars

https://biopharmawebinars.com/webinars/overcoming-bottlenecks-in-pat-deployment-bridging-the-gap-between-lab-manufacturing/

Overcoming Bottlenecks in PAT Deployment: Bridging the Gap Between Lab & Manufacturing

Presented by Luc Nguyen, Global Head of Process Analytical Technologies (PAT) within MSAT at Sanofi, Ramila Peiris, Global Head of Process Data Management, Machine Learning, and AI Platform MSAT at Sanofi, Maryann Cuellar, Life Science Industry Manager at Endress+Hauser Optical Analysis, Michael Sachpekidis, Global Account Director at SciY
14th October 2026

https://biopharmawebinars.com/webinars/managing-analytical-procedure-lifecycles-resolving-longstanding-mass-spectrometry-challenges-for-emerging-nitrosamine-and-ndsri-impurities/

Managing Analytical Procedure Lifecycles: Resolving Longstanding Mass Spectrometry Challenges for Emerging Nitrosamine and NDSRI Impurities

Presented by Jinhui Zhang, Chemist at FDA/CDER, Andrew Teasdale, Principal Consultant at Nelson Labs
15th October 2026

https://biopharmawebinars.com/webinars/assessing-the-use-of-solid-phase-cytometry-for-rapid-bioburden-testing-2/

Assessing the Use of Solid-Phase Cytometry for Rapid Bioburden Testing

Presented by Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca
22nd October 2026

https://biopharmawebinars.com/webinars/navigating-particulate-matter-analysis-in-biologic-drug-products-a-critical-evaluation-of-flow-imaging-and-light-obscuration-for-product-quality-assessment/

Navigating Particulate Matter Analysis in Biologic Drug Products: A Critical Evaluation of Flow Imaging and Light Obscuration for Product Quality Assessment

Presented by Ashwinkumar Bhirde, PhD. FDA/CDER/OPQ, Senior Research Scientist, Louise Brogan, PhD, Marketing Director, Yokogawa Fluid Imaging Technologies and Amber Raines, Ph.D., Senior Director of Client Project Management at Coriolis Pharma, U.S.
27th October 2026

 

On Demand Webinars

https://biopharmawebinars.com/webinars/building-characterization-assays-to-support-early-stage-sarna-development-and-qc-alignment/

Building Characterization Assays to Support Early-Stage saRNA Development and QC Alignment

Presented by Yun-Ting Kao, Senior Scientist at Immunomic Therapeutics
07th October 2026

https://biopharmawebinars.com/webinars/leveraging-next-generation-sequencing-for-adventitious-agent-testing-paciras-quality-control-strategy-and-lessons-learned/

Leveraging Next-Generation Sequencing (NGS) for Adventitious Agent Testing: Pacira’s Quality Control Strategy and Lessons Learned

Presented by Po-Yi Ho, Associate Director / Analytical Development / Cell & Gene Therapies at Pacira Biosciences, and Quynh Ton, Ph.D, Regional Sales Director: NGS Application Specialist at Pathoquest
06th October 2026

https://biopharmawebinars.com/webinars/aseptic-manufacturing-for-mrna-adcs-and-novel-biologics/

Aseptic Manufacturing for mRNA, ADCs, and Novel Biologics

Presented by Francesco Cicirello, Senior Director, Global Quality Compliance – BioNTainer at BioNTech and Scott Harper, Director of Global Sales, Aseptic Filling, at Cytiva
29th September 2026

https://biopharmawebinars.com/webinars/analytical-assessment-of-leachables-in-biological-drug-products-fda-approach-in-reviewing-information-and-representative-review-cases/

Analytical Assessment of Leachables in Biological Drug Products: FDA’s Approach to Reviewing Information and a Representative Review Case

Presented by Andrey Sarafanov, PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research, Sarah Brophy, Global Scientific Director, E&L Element Materials Technology
24th September 2026